|
Asston Pharmaceuticals Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
84.27 Cr.
|
P/BV
|
2.17
|
Book Value (Rs.)
|
45.65
|
|
52 Week High/Low (Rs.)
|
126/60
|
FV/ML
|
10/1000
|
P/E(X)
|
21.81
|
|
Bookclosure
|
|
EPS (Rs.)
|
4.54
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 4.92 | 6.90 | 2.37 | 1.89 | 91.63 |
| Diluted EPS (Rs.) | 4.92 | 6.90 | 2.37 | 1.89 | 91.63 |
| Cash EPS (Rs.) | 4.92 | 7.03 | 18.00 | 15.62 | 108.43 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 45.65 | 17.09 | 81.55 | 28.37 | 128.68 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 45.65 | 17.09 | 81.55 | 28.37 | 128.68 |
| Revenue From Operations / Share (Rs.) | 29.92 | 39.93 | 198.83 | 93.40 | 8034.07 |
| PBDIT / Share (Rs.) | 6.52 | 10.73 | 35.73 | 31.00 | 258.78 |
| PBIT / Share (Rs.) | 6.14 | 10.60 | 35.08 | 30.48 | 241.98 |
| PBT / Share (Rs.) | 5.40 | 9.09 | 23.18 | 20.18 | 121.47 |
| Net Profit / Share (Rs.) | 4.54 | 6.90 | 17.35 | 15.09 | 91.63 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 21.79 | 26.87 | 17.96 | 33.19 | 3.22 |
| PBIT Margin (%) | 20.51 | 26.55 | 17.64 | 32.63 | 3.01 |
| PBT Margin (%) | 18.03 | 22.76 | 11.65 | 21.60 | 1.51 |
| Net Profit Margin (%) | 15.17 | 17.27 | 8.72 | 16.16 | 1.14 |
| Return on Networth / Equity (%) | 9.94 | 40.35 | 21.27 | 53.20 | 71.20 |
| Return on Capital Employeed (%) | 12.25 | 50.62 | 33.52 | 54.61 | 9.58 |
| Return On Assets (%) | 7.48 | 15.37 | 6.71 | 7.71 | 1.32 |
| Long Term Debt / Equity (X) | 0.09 | 0.21 | 0.25 | 0.91 | 17.67 |
| Total Debt / Equity (X) | 0.13 | 0.67 | 1.07 | 2.64 | 17.67 |
| Asset Turnover Ratio (%) | 0.63 | 1.03 | 0.91 | 0.00 | 1.77 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 4.51 | 1.80 | 1.52 | 1.09 | 1.36 |
| Quick Ratio (X) | 4.43 | 1.75 | 1.40 | 0.93 | 1.08 |
| Inventory Turnover Ratio (X) | 34.32 | 23.23 | 10.60 | 0.00 | 8.69 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 8.77 | 7.09 | 3.00 | 3.01 | 2.15 |
| Interest Coverage Ratio (Post Tax) (%) | 7.11 | 5.55 | 2.46 | 2.47 | 1.76 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 65.96 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV / Net Operating Revenue (X) | 2.59 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV / EBITDA (X) | 11.88 | 0.00 | 0.00 | 0.00 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 2.44 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price / BV (X) | 1.60 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price / Net Operating Revenue (X) | 2.44 | 0.00 | 0.00 | 0.00 | 0.00 |
| EarningsYield | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 |
